Important supply shortage information for people in Ireland living with type 2 diabetes using Victoza® (liraglutide) solution for injection in pre-filled pen

Novo Nordisk Limited, Ireland would like to inform you of an expected supply shortage with Victoza® solution for injection in pre-filled pen, which is used to reduce high blood glucose levels in people with type 2 diabetes.


A shortage of both Victoza® 2 and 3-pen packs is expected in Ireland in early December 2023. A return to stock is expected by June 2024.


The supply shortage is not related to a quality defect of the products or a safety issue.


If you are currently prescribed Victoza ®

  • you should contact your Healthcare Professional.
  • Do not stop taking Victoza® or change your Victoza® treatment unless you have agreed it with your Healthcare Professional as this may result in high blood glucose levels (shown in tests) and high levels of ketones.
  • All Healthcare Professionals have been informed of this shortage.


Diabetes Ireland will continue to provide updates on this supply situation as new information becomes available.


Company contact point

Further information can be obtained by contacting Novo Nordisk Limited, Ireland on 01 8629700 or [email protected].